FDA Seeks New Powers Over Drug Ads in 2026
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.
Drug Policy
1 article tagged "Drug Policy"
1 article tagged "Drug Policy"
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.